The synergistic anti-tumor effect of schisandrin B and apatinib.
J Asian Nat Prod Res
; 22(9): 839-849, 2020 Sep.
Article
em En
| MEDLINE
| ID: mdl-31364407
ABSTRACT
The synergistic anti-tumor effect of schisandrin B (Sch.B) and apatinib was investigated in vitro. The CCK-8 assay revealed that Sch.B enhanced the inhibition of apatinib on cell proliferation by arresting cell cycle in G0/G1 phase. Sch.B also potentiated the suppression of apatinib on cell migration and invasion, by means of wound-healing and transwell invasion assay. Flow cytometry results showed that Sch.B enhanced apoptosis induced by apatinib. The results were confirmed by western blot analysis of the proteins MMP-9, and Bax caspase-9, and -12. These results suggest that combining apatinib and Sch.B is an effective therapeutic strategy for preventing GC progression. [Formula see text].
Palavras-chave
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Apoptose
/
Ciclo-Octanos
Idioma:
En
Ano de publicação:
2020
Tipo de documento:
Article